Product Overview

Letzol-Well 2.5 (Letrozole 2.5mg Tablets) is a trusted aromatase inhibitor widely prescribed for the treatment of hormone-dependent breast cancer in postmenopausal women. By lowering estrogen levels in the body, it helps slow or stop the growth of certain types of breast tumors.

This medicine is commonly recommended in both early-stage and advanced breast cancer, as well as to prevent recurrence after initial cancer treatment.

Key Benefits of Letzol-Well 2.5

• Powerful estrogen-lowering effect for hormone-sensitive cancers

• Improves long-term outcomes in breast cancer patients

• Reduces the risk of cancer recurrence

• Convenient oral tablet form for daily use

• Manufactured with high-quality standards for consistent results

Indications

• Treatment of hormone receptor-positive breast cancer in postmenopausal women

• Adjuvant therapy for early-stage breast cancer

• Management of advanced or metastatic breast cancer

• Prevention of cancer recurrence after initial treatment

Possible Side Effects

• Hot flashes, fatigue, headache, or dizziness

• Nausea, joint or muscle pain

• Increased risk of osteoporosis (with prolonged use)

• If side effects persist or worsen, consult a healthcare professional immediately

Product Specifications

• Brand Name: LETZOL-WELL 2.5

• Composition: Letrozole Tablets USP 2.5mg

• Form: Tablet (Oral use)

• Packaging: 10x1x5 Tablets

• Manufacturer: Nextwell Pharmaceutical Pvt Ltd.

The post LETZOL-WELL 2.5 LETROZOLE TABLETS USP 2.5 MG appeared first on nextwell.